The Antibiotic Pipeline Is Contracting While Resistance Accelerates
The 2026 AMR Benchmark Report identified 7 late-stage products targeting the most dangerous resistant pathogens. Seven, for the entire planet. This is not a biology problem that got away from us; it is a funding structure that was never built to solve it.
By Kai Brighton · 3 min read